Azurity Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Massachusetts, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
8 Cabot Rd Ste 2000, Woburn, Massachuset...Phone Number
(800) 461-7449Website
www.azurity.comRevenue
$270.1 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
8
1
2
2
2
1
About Azurity Pharmaceuticals
Azurity Pharmaceuticals is a privately held biopharmaceutical company focused on developing and delivering innovative, high-quality medicines for underserved patients. With a diverse portfolio across multiple therapeutic areas and dosage forms, the company leverages advanced commercial strategies, data, and digital tools to enhance reach and engagement, aiming to improve patient outcomes and address unmet medical needs globally.Explore more
Azurity Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Azurity Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Azurity Pharmaceuticals had a recent Job posting/layoffs
Check out if Azurity Pharmaceuticals is spiking on competitors!
Funding: Get notified immidiatlly once Azurity Pharmaceuticals has new funding data
Product Launch: Get notified when Azurity Pharmaceuticals launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Azurity Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Azurity Pharmaceuticals recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Azurity Pharmaceuticals
Website visits: Recent activity has been detected on your website
Azurity Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Azurity Pharmaceuticals
Find 2 more new buyers
Compare Similar Companies to Azurity Pharmaceuticals
Compare insights from companies similar to Azurity Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Azurity Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Azurity Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Azurity Pharmaceuticals.
Azurity Pharmaceuticals Tech Stack
A closer look at the technologies used by Azurity Pharmaceuticals
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Azurity Pharmaceuticals News & Media
ACA Pharma and Azurity Pharmaceuticals Announce Approval of Feraheme® and Ferabright™ in Macau
NEW YORK, NY, UNITED STATES, May 21, 2026 /EINPresswire.com/ -- ACA Pharma and Azurity Pharmaceuticals announced that Feraheme® and Ferabright™ have each received regulatory approval in Macau, marking an important step in expanding access to ferumoxytol- …Azurity Pharmaceuticals Announces the Availability of ARYNTA™ (lisdexamfetamine dimesylate) Oral Solution, CII
Woburn, MA, April 06, 2026 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals, Inc. announced that ARYNTA™ (lisdexamfetamine dimesylate) Oral Solution is now available in the United States for treating ADHD in adults and pediatric patients 6 years and older. Arynta, a ready-to-use lisdexamfetamine oral solution that may be stored at room temperature between 68°F to 77°F (20°C to 25°C),1 received FDA approval in June 2025.Azurity Pharmaceuticals Announces FerabrightTM (ferumoxytol injection) Now Available in the U.S. for Magnetic Resonance Imaging of the Brain
Ferabright is the first and only iron-based contrast agent for MRI in the brain Ferabright is the first and only iron-based contrast agent for MRI in the brainAzurity Pharmaceuticals Announces ARYNTA™ (lisdexamfetamine dimesylate) Oral Solution, CII
Woburn, MA, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals, Inc. announced that ARYNTA™ (lisdexamfetamine dimesylate) Oral Solution will be available mid-2026 for treating ADHD in adults and pediatric patients 6 years and older. Arynta, a ready-to-use lisdexamfetamine oral solution that may be stored at room temperature between 68°F to 77°F (20°C to 25°C),1 received FDA approval in June 2025.
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Azurity Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Azurity Pharmaceuticals is a privately held biopharmaceutical company focused on developing and delivering innovative, high-quality medicines for underserved patients. With a diverse portfolio across multiple therapeutic areas and dosage forms, the company leverages advanced commercial strategies, data, and digital tools to enhance reach and engage... Read More
